Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study-Reference-Cited by-同舟云学术

Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study

Published:2016-01-25 Issue:5 Volume:59 Page:296-303
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Tadec Laurent¹²,Talarmin Jean-Philippe³,Gastinne Thomas⁴,Bretonnière Cédric⁵,Miegeville Michel¹²,Le Pape Patrice¹²,Morio Florent¹²

Affiliation:

1. Département de Parasitologie et Mycologie Médicale; EA1155 - IICiMed; Faculté de Pharmacie; Université de Nantes; Nantes Atlantique Universités; Nantes France

2. Laboratoire de Parasitologie-Mycologie; CHU de Nantes; Nantes France

3. Service de Maladies Infectieuses et Tropicales; CHU de Nantes; Nantes France

4. Service d'Hématologie Clinique; CHU de Nantes; Nantes France

5. Service de Réanimation Médicale; CHU de Nantes; Nantes France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Reference40 articles.

1. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis;Zaoutis;Clin Infect Dis,2005

2. Candidaemia in Europe: epidemiology and resistance;Tortorano;Int J Antimicrob Agents,2006

3. Epidemiology of invasive candidiasis: a persistent public health problem;Pfaller;Clin Microbiol Rev,2007

4. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry;Horn;Clin Infect Dis,2009

5. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis;Guery;Intensive Care Med,2009

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mechanism study on the synergistic effects of rifapentine and fluconazole against fluconazole-resistant Candida albicans in vitro;Heliyon;2024-03

2. Targeting yeast topoisomerase II by imidazo and triazoloacridinone derivatives resulting in their antifungal activity;Scientific Reports;2024-02-13

3. Incidence, Species Distribution, and Antifungal Susceptibility of Candida Bloodstream Infections in a Tertiary Algerian Hospital;ECM 2023;2023-12-26

4. Unresolved issues in the diagnosis of catheter related candidemia: A position paper;Revista Española de Quimioterapia;2023-11-13

5. Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo;Expert Review of Anti-infective Therapy;2023-10-20